Search

Search Constraints

You searched for: Author/Creator van Campenhout, Margo J. H.

Search Results

1. Development and validation of a model for hepatitis B e antigen seroconversion in entecavir‐treated patients with chronic hepatitis B. Issue 8 (21st November 2019)

2. Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss. Issue 2 (21st November 2020)

3. Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up. Issue 1 (27th September 2018)

4. Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B. Issue 4 (28th January 2019)

5. Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg‐positive chronic hepatitis B. Issue 6 (17th March 2020)